Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8291-8300 of 13616

Page
per page
  1. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  2. Pazopanib Hydrochloride
    A8347 Pazopanib Hydrochloride
    Summary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
      ≥11.1 mg/mL
  3. Varlitinib (ARRY334543)
    A8365 Varlitinib (ARRY334543)
    Summary: ErbB inhibitor
      ≥23.35 mg/mL
  4. PF-04691502
    A8499 PF-04691502
    Target: Akt|PI3K|mTOR
    Summary: PI3K/mTOR (FRAP) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.63 mg/mL
  5. Betamethasone Dipropionate
    A8378 Betamethasone Dipropionate
    Summary: Glucocorticoid receptor agonist
      ≥22.75 mg/mL
  6. LEE011
    A8641 LEE011
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
  7. GDC-0834
    B3228 GDC-0834
    Summary: potent and selective BTK inhibitor
      Soluble in DMSO
  8. Daunorubicin
    B1099 Daunorubicin
    Summary: DNA topoisomerase II inhibitor
      ≥83.33 mg/mL
  9. ONO-RS-082
    C5625 ONO-RS-082
    Summary: reversible inhibitor of Ca2+-independent phospholipase A2
      ≥50 mg/mL
  10. Amyloid Beta-Peptide (1-40) (human)
    A1124 Amyloid Beta-Peptide (1-40) (human)
     8 Citation
    Summary: residues 1-40 of human amyloid-beta
      insoluble in EtOH; ≥23.8 mg/mL

Items 8291-8300 of 13616

Page
per page